although not by others (20) , to function in human erythrocytes as well. Unlike catalase, GSH peroxidase efficiently detoxifies low levels of H202, doing so by reversibly oxidizing reduced glutathione (17) . If one assumes that other thiols in the erythrocyte are in oxidation-reduction equilibrium with GSH, and since intact globin and membrane thiols are crucial to the integrity of hemoglobin (3) and the survival of the cell (21, 22) , respectively, this mechanism for detoxifying low levels of H202 demands for preservation of the steady state a compensatory system for restoring glutathione to the reduced state. This compensatory restoration is catalyzed by the enzyme glutathione reductase which, in turn, utilizes as a co-factor TPNH generated in the first two steps of the hexose monophosphate (HMP) shunt. As predicted by Mills and Randall (10) and as demonstrated in vitro by Cohen and Hochstein (11, 17) , impairment of the HMP shunt by a deficiency of glucose-6-phosphate dehydrogenase (G6PD) results in GSH "instability" in the presence of H202 in vitro, and hemolysis is presumed to follow.
It has recently been suggested (17) that only GSH peroxidation is utilized by erythrocytes in degrading the low concentrations of H202 likely to be present under physiologic conditions. The following studies, performed in several members of a Swiss family with hereditary acatalasia, provide further information concerning the relative utilization of the catalasic versus the peroxidative mechanisms for dissipation of erythrocyte H202. The findings have been reported in a preliminary form elsewhere (23) .
Methods
Subjects. From the "V" family described by Aebi, Heiniger, Butler, and Hassig (24) , two females and one male with acatalasia (homozygous) and two males and one female with hypocatalasia (heterozygous) served as erythrocyte donors. In confirmation of the findings of these workers, routine blood values, including reticulocyte percentages, were normal in all family members studied. Methemoglobin and sulfhemoglobin were absent from freshly drawn blood, and there were no inclusion bodies. Cellular concentrations of GSH were normal and were stable when erythrocytes were exposed to acetylphenylhydrazine (18) . None of the acatalasic subjects had physical or historical evidence of the severe gangrenous oral infections or other medical difficulties reported in acatalasic Japanese (25, 26) . The propositus was originally identified in 1961 during a screening study of 38 ,775 blood samples from Swiss males entering military service. Quantitative analyses of whole blood catalase by a perborate titrimetric method (27) and a spectrophotometric method (28) were previously reported to range from 0.1 to 1.3% of normal levels in the acatalasic subjects and were roughly 50% of normal in their hypocatalasic relatives (29) . None of the acatalasic hemolysates showed precipitation in Ouchterlony diffusion tests with an anticatalase rabbit serum (29) . In the present studies, as judged by a permanganate titration method (30) , catalase was absent both in acatalasic erythrocytes and leukocytes. During these studies neither the family members nor the normal donors of blood were receiving medications, except as noted.
Studies in vitro. Fresh blood from family members and from hematologically normal control subjects was drawn into heparin and centrifuged at 3,000 rpm. The buffy coat was removed, and the cells were resuspended in phosphate buffered saline,1 pH 7.4. After recentrifugation and a second removal of any remaining buffy coat, the erythrocytes were suspended in buffered saline to a concentration of 35%o. Leukocytes in these washed suspensions numbered less than 1,000 per mm8. When indicated, glucose was added to a final concentration of 0.015 M. After removal of a sample of cells for initial metabolic determinations, the remaining cell suspension was incubated at 370 C in stoppered vessels with agitation in a water bath. At intervals thereafter samples were removed for further metabolic determinations. In studies requiring incubation for prolonged periods, 500 U of penicillin G and 250 ug of streptomycin were added to each milliliter of sterile washed cell suspension; incubation in such studies was carried out in stoppered tubes kept at 370 C without agitation. In all experiments, the metabolism of acatalasic erythrocytes was compared to that of erythrocytes from normal subjects incubated at the same time under identical conditions. The selected oxidant drugs, of reagent grade, were added at 0.1 vol in buffered saline at the onset of incubation. In peroxide diffusion experiments, 30% H2022 was added to the center wells of Warburg flasks containing the erythrocyte 1 Three parts isotonic saline plus one part isotonic (0.12 M) phosphate buffer, pH 7.4.
2 As Superoxol, Merck and Co., Inc., Rahway, N. J.
suspensions, as in the technique described by Cohen and Hochstein (11) . Methemoglobin, sulfhemoglobin, and total hemoglobin were measured on filtered hemolysates by the method of Evelyn and Malloy (31) . The appearance of incubated cells was examined microscopically in wet preparations after resuspension in autologous plasma. Supravital staining with aqueous solutions of crystal violet, made isotonic with NaCl, was employed in examinations for inclusion bodies. A semiquantitative assay of precipitated hemoglobin was obtained by comparing the optical density of cyanide-treated hemolysates at 635 m/A ("L2" in the Evelyn-Malloy method) before and after filtration through double thickness Whatman 12 filter paper. From this a "turbidity index" was devised.
Turbidity index = L°-LF LT where Lo = OD of cyanide-treated hemolysate at 635 m/u before filtration, LF= OD of cyanide-treated hemolysate at 635 mu after filtration, and LT = OD of total hemolysate hemoglobin measured as cyanmethemoglobin at 540 m/u. The pH of erythrocyte suspensions was measured in a Beckman model G pH meter and, when compared over the short periods of incubation, suspensions of acatalasic and normal cells did not differ significantly. Erythrocyte lactate production by the lactate dehydrogenase method3 (32) , and glucose consumption by the SomogyiNelson (33) or glucose oxidase (34) methods, were determined in duplicate assays from duplicate incubation flasks agitated for 4 hours at 37°C. Inhibition of erythrocyte GSH by buffered solutions of N-ethylmaleimide (NEM) and iodoacetate was effected as described previously (21) . The method of Grunert and Phillips (35) , as modified by Beutler (36) , was used to assay the cellular content of GSH. Measurements of radioactive CO2 derived from cell suspensions incubated with C'-l-1 glucose 4 were made utilizing stoppered incubation bottles containing removable plastic wells of hyamine as described previously (37) . Briefly, 0.2 ,uc of tracer quantities of C1'-glucose was added to 2 ml of a 35% cell suspension containing 150 mg per 100 ml carrier glucose. After agitation for 4 hours at 37°C, 0.2 ml of 1 N H2SO4 was added through the rubber diaphragm covering the incubation bottle. The evolved C1' 02 was trapped in the plastic well containing hyamine and counted in a methanoltoluene solution of 2,5-diphenyloxazole-p-bis-2-(5-phenyloxazolyl)benzene5 in a Packard Tri-Carb liquid scintillation counter.6 From a knowledge of the counts of C1' glucose added, the total glucose consumption and the C"02 Erythrocyte survival studies utilizing erythrocytes labeled with Cr' sodium chromate7 were performed as described previously (38) . Washed, labeled erythrocytes from two acatalasic donors were injected into two normal, compatible recipients, and their disappearance was followed for 1 month. As a test of the ability of the primaquine8 used in these studies to cause oxidative hemolysis in vivo, a daily dose of 30 mg was administered to a normal recipient of Cr'-labeled, G6PD-deficient erythrocytes; rapid destruction of the labeled cells was observed after drug ingestion.
Results
Effects of oxidant drugs on acatalasic erythrocytes. Washed erythrocyte suspensions from acatalasic and normal subjects were incubated simultaneously in identical glucose-free media. Oxidant damage by various compounds was assessed by the formation of methemoglobin and the appearance of precipitated hemoglobin inclusions (Heinz bodies) in the incubated erythrocytes.
H202 was added to erythrocytes slowly and continuously by diffusion or by the action of various concentrations of ascorbic acid. The latter compound gradually and stoichiometrically generates H202 in the presence of oxyhemoglobin by the process of "coupled oxidation" (5) . As shown in Table I ERYTHROCYTES. When sterile incubation was performed in glucose-free media (left), erythrocytes from two acatalasic siblings (black symbols) accumulated methemoglobin (upper) and sulfhemoglobin (middle) more rapidly and to greater degree than did those from two normal subjects (white symbols). Denaturation and precipitation of hemoglobin as measured by turbidity (lower) and the formation of Heinz bodies (parentheses) were also more prominent in incubated acatalasic erythrocytes. Glucose addition prevented this hypersusceptibility (right). The experiment portrayed is representative of three performed. Each point represents one determination on a sample of blood from one donor. The drop in sulfhemoglobin level in one of the acatalasic specimens at 3 days without glucose presumably reflects removal of the pigment by its precipitation (2).
potency of primaquine was enhanced, particularly employed, hydroquinone, a postulated intermediate for acatalasic erythrocytes. This was evidenced in the in vivo metabolic degradation of primaquine by their greater accumulation of both methemo-and other 8-amino quinonolones (12) , produced globin and sulfhemoglobin. In the concentration Heinz bodies only in acatalasic erythrocytes, in which it had generated 2 to 3 times the quantity of methemoglobin generated in normal cells. Finally, both cell types underwent oxidant damage by acetylphenylhydrazine, but acatalasic cells showed no hypersusceptibility to this drug regardless of its concentration.
Effects of prolonged incubation on acatalasic erythrocytes. Under aseptic conditions washed erythrocytes from acatalasic and normal donors were simultaneously incubated under identical conditions for 3 days. In glucose-free media (left portion, Figure 1 ) methemoglobin appeared sooner and accumulated to a greater extent in acatalasic than in normal erythrocytes (left upper, Figure  1 ). Similarly, so-called "sulfhemoglobin," a mixture of irreversibly denatured hemoglobin products, accumulated more rapidly in acatalasic cells (left middle portion, Figure 1 ). Precipitated hemoglobin was estimated by a "turbidity index" (see Methods) and by estimating the number of Heinz bodies. As seen in the lower left portion of Figure 1 , the turbidity of hemolysates from incubated acatalasic erythrocytes increased progressively with time and exceeded that from simultaneously incubated normal cell suspensions. Acatalasic erythrocytes contained numerous Heinz bodies after 48 hours of incubation, whereas similarly incubated normal cells contained none. The response of hypocatalasic erythrocytes to prolonged sterile incubation was indistinguishable from that of normal erythrocytes (not shown).
The role of glycolysis in the prevention of oxidative damage to acatalasic erythrocytes. When glucose was added to the erythrocyte suspensions (right portion of Figure 1 ), acatalasic erythrocytes were no longer hypersusceptible to the oxidative damage of prolonged incubation. Glucose also protected acatalasic erythrocytes from damage due to oxidant drugs. As shown in Table II Figure 2) . Noteworthy was the fact that methemoglobin levels of these acatalasic cells were negligible as GSH was decreasing, but then rose significantly only as GSH activity disappeared (right lower, Figure 2 ). The disappearance of GSH and the accumulation of methemoglobin was prevented by the addition of glucose to the incubations (not shown).
If cellular GSH was experimentally inhibited, by binding with N-ethylmaleimide (NEM), acatalasic erythrocytes became extremely vulnerable to oxidative damage by H202-generating systems.
In acatalasic cells, briefly incubated in air, the addition of NEM sufficient to bind all cellular GSH resulted in the accumulation of large quantities of methemoglobin and numerous Heinz bodies (top portion, Figure 3 ). Simple inhibition of glycolysis by 8 mM fluoride had no comparable effect in simultaneously incubated acatalasic cells. When incubated with 5 mM ascorbic acid, the oxidative injury to NEM-treated, acatalasic erythrocytes was rapid and massive, over half of the hemoglobin of these cells being oxidized in 2 hours (lower portion, Figure 3) . No methemoglobin was detected at this time in fluoridated cells similarly treated (lower portion, Figure 3 ). After 4 hours the difference in methemoglobin levels of NEM and fluoride-treated cells remained striking, and Heinz bodies were more obviously apparent in the sulfhydryl-inhibited than in the fluoridated cells. Similar results were obtained when iodoacetate replaced NEM as a sulfhydryl inhibitor. In simultaneous experiments NEM was found to produce no oxidation of hemoglobin in normal cells, even when treated with ascorbic acid (not shown).
The hexosemonophosphate (HMP) shunt in acatalasic erythrocytes. Although the over-all rate of glucose utilization was normal in untreated acatalasic erythrocytes, the proportion metabolized via the HMP shunt was increased to approximately thrice normal (Table IV) . As noted above, the glucose utilization of acatalasic erythrocytes was greatly increased by exposure to peroxide-generating systems that had no effect on this function in normal cells (Table III) . This * Two samples of each erythrocyte suspension from three acatalasic and four normal donors were incubated in parallel with agitation for 4 hours at 370 C. The suspending medium for each paired incubation was identical and contained 0.015 M glucose with or without added H202. t H02 was added in "D" experiments by continuous diffusion of 30% H202 from the center wells of Warburg flasks into the surrounding erythrocyte suspension (see Methods). In "A" experiments, H2Os was generated by the addition of 5 mM ascorbic acid directly to the blood suspensions.
increase in the presence of ascorbic acid was entirely through stimulation of the HMP shunt (Table IV) . Thus, ascorbic acid doubled the over-all consumption of glucose by acatalasic erythrocytes and stimulated metabolism in the HMP shunt twelvefold. Despite this enhancement formation of lactate by these cells was unaltered. In contrast, both total glucose consumption and the activity of the HMP shunt were little affected in normal cells exposed to the small amount of ascorbic acid utilized in these studies.
From the foregoing it might be predicted that erythrocytes devoid of catalase and also deficient in HMP shunt activity should be extremely vul- 
FIG. 4. EFFECT OF CATALASE INHIBITION ON GLUCOSE-6-PHOSPHATE-DEHYDROGENASE-DEFICIENT ERYTHROCYTES EX-
POSED TO H202. The inhibition of erythrocyte catalase by sodium cyanide (white circles) potentiated the oxidative denaturation of hemoglobin to sulfhemoglobin in G6PD-deficient erythrocytes that were exposed to H202 by treatment with 30 mM ascorbic acid. The experiment depicted is representative of five performed, utilizing erythrocytes from two male G6PD-deficient subjects. Each point represents a single determination in blood from one subject. nerable to oxidant damage by peroxides. This was found to be the case as shown in Figure 4 . When erythrocytes from a Negro male with deficiency of glucose-6-phosphate dehydrogenase (G6PD), the Figure 5 ) and of hemoglobin (lower portion, Figure 5 ) more rapidly than occurs in cells that are geneti-CYANIDE cally devoid of catalase (Figures 1 and 2 ). Re-NO ADDITION cently, similar concentrations of this compound have been shown to double the rate of HMP shunt metabolism in erythrocytes (39) . In contrast cyanide was found to be a comparably potent in-AZIDE hibitor of catalase without affecting HMP shunt metabolism (39) but tended to stabilize glutathione against autoxidation both within cells (Figure 5 ) and in solution. In addition, cyanide was found to resist elution from the cells containing methemoglobin more than did azide (40).9
AZIDE
Effects of primaquine and ascorbic acid ingestion on the survival of acatalasic erythrocytes in vivo. Erythrocytes from two acatalasic donors were labeled with Na2Cr51O4 and injected into two normal, compatible recipients. As shown in Figure 6 , the survival of cells from one donor (M. V.) during the 13-day period of observation 
Discussion
The present studies help clarify the mechanisms of hemolysis caused by various oxidant compounds and shed light on the relative roles of catalase and of glutathione in the detoxification of hydrogen peroxide.
The role of H202 in oxidative hemolysis. As a class, compounds (such as aniline dyes, sulfonamides, and antimalarials) that cause Heinz body hemolytic anemias are capable of acting as catalysts in oxidation-reduction systems (1, 6, 7, 2) . The essence of this process is the transfer of electrons from cellular components to molecular oxygen, with the resulting progressive oxidation of thiols and of hemoglobin (2, 3), culminating in the granular precipitation of hemoglobin into Heinz bodies (2, 4) . It is debated, however, whether the ultimate agent of oxidative injury is the partially oxidized drug (e.g., a semiquinone) or the partially reduced oxygen (i.e., hydrogen peroxide), since both may be formed during the reaction and since both function as oxidizing free radicals. This question assumes importance since there exist natural systems, catalase and peroxidases, for detoxifying the latter, and deficiencies thereof might predispose toward hemolytic anemia. Tarlov and colleagues (12, 41) have suggested that hypocatalasemia and circulating "anticatalase" factors that occur after the ingestion of oxidant drugs might be crucial in oxidative hemolysis. Cohen and Hochstein, on the other hand, have emphasized the finding of Keilin and Hartree (16) that catalase is relatively inefficient in decomposing low concentrations of H)20 and have demonstrated that continuous, low levels (less than 10-6 M) of H202, as are obtained in a well-diffusion system (11), will cause oxidative damage to erythrocytes regardless of normal levels of catalase. Since glucose protects erythrocytes against low levels of H)2, unless the cells are deficient in G6PD (11) (11) or by generation during the coupled oxidation of ascorbic acid and hemoglobin (5) . These cells were hypersusceptible as well to steady low levels of H202 generated endogenously during prolonged aerobic incubation. In the absence of glucose, low levels of H202 initially caused oxidation of GSH followed by the formation of methemoglobin, sulfhemoglobin, and the precipitation of hemoglobin (as Heinz bodies) in acatalasic but not in normal erythrocytes. In the presence of glucose these changes were suppressed. Thus the capacity of acatalasic erythrocytes to compensate for their enzymatic deficiency requires glucose-consuming metabolism, and with low levels of H202 this compensation is complete. In the present studies the underlying hypersusceptibility of these cells to oxidative damage was unmasked by depriving them of glucose. However, their inherent vulnerability to oxidation was apparent even in the presence of glucose as evidenced by their increased "resting" HMP shunt activity and by the further inordinate acceleration thereof when these cells were exposed to H202. Although direct evidence is lacking that increased HMP shunt activity in catalase-deficient erythrocytes reflects accumulation of H202, this inference is supported by the findings: 1) that erythrocytes exposed to a variety of H2O2-generating systems in vitro manifest heightened HMP shunt metabolism (39) ; 2) that the enzymatic sequence whereby such a metabolic response might occur has been described (10); and 3) that the necessary enzymes for this response (glutathione peroxidase and glutathione reductase) have been demonstrated in erythrocytes (10, 15, 17, 19) . Furthermore, since normal erythrocytes were uninjured by low levels of H2O2, and since their metabolism was not significantly affected, it seems reasonable to conclude that catalase is a primary line of defense against H202 in the erythrocyte. Even half of the level of catalase appeared sufficient, for the heterozygotic individuals were normally resistant to H202. Only when catalase was virtually absent as in homozygous individuals was there evidence of a compensatory HMP shunt stimulation. Since this defensive response was little affected by fluoride, but markedly inhibited by the GSHblocking compound, NEM, the mechanism of this second line of defense against H202 is presumed to be through the GSH peroxidase mechanism described by others (10, 15, 17, 19) . Thus, in acatalasia, the oxidative challenge of H202, whether spontaneously generated or drug-induced, both stimulates and is offset by hexosemonophosphate shunt activation.
It was possible in these studies to "assay" hemolytic drugs for their dependence on peroxide generation by noting their effect on acatalasic cells. Thus, the established ability of ascorbic acid to form H202 stoichiometrically during its coupled oxidation with oxyhemoglobin was attested to by finding that low levels of ascorbic acid caused methemoglobin selectively in acatalasic erythrocytes. With this assay, acatalasic cells were found not to be hypersusceptible to freshly prepared primaquine. If altered, however, by storage or ultraviolet irradiation, this drug acquired the capacity to generate hydrogen peroxide, as inferred from these studies. It is of interest that Carson (43) had noted an enhanced oxidative activity of primaquine after subjecting it to ultraviolet irradiation. On the other hand, acetylphenylhydrazine, a prototype of compounds that induce Heinz body hemolytic syndromes, produced oxidative injury equally in normal and in acatalasic erythrocytes. Thus, it did not appear to act through generating H202. Furthermore, previous studies (2) have shown that after the inhibition of catalase by cyanide, oxidative damage of hemoglobin treated with acetylphenylhydrazine is diminished, rather than abetted, suggesting further that H202 is not involved in the action of this drug.
The role of catalase under physiologic conditions and during autoxidation. As compared to normal cells, fresh erythrocytes from subjects with acatalasia showed heightened HMP shunt activity, with the oxidation of glucose-1-C'4 proceeding at over three times the normal rate (Table  IV) . Thus, even at the very low levels of H202 generated endogenously in erythrocyte suspensions in vitro, a compensatory acceleration of the HMP shunt was required to offset the absence of catalase. In confirmation of this, acatalasic cells were found to be more "GSH unstable" than normal on sterile incubation without glucose, and they more rapidly manifested the hemoglobin oxidation and Heinz body formation that occur in erythrocytes on sterile incubation for several days (2) . Since acatalasic erythrocytes depend constantly on heightened HMP shunt activity and since enzymes of this pathway diminish with cell age, it might be predicted that cell survival would be shortened if H202 is involved in cellular aging. Whether such is the case is uncertain from the present studies with Cr51, for this method is not dependable in evaluating relatively slight reductions in erythrocyte lifespan. It is apparent, however, that erythrocyte lifespan is not markedly diminished.
It seems clear from these studies that catalase in erythrocytes is a first line of defense against H202 but that under most circumstances it is dispensable. In its absence, H202 is dissipated primarily by the oxidation of GSH through the action of a glutathione peroxidase, and in response to this the metabolism of glucose through the HMP shunt is necessarily increased. Situations in which both catalase and the HMP shunt are markedly deficient would presumably be lethal.
Summary
The role of peroxides in erythrocyte aging and in drug-induced hemolysis and the effects of H202 on the thiol and glucose metabolism of erythrocytes were investigated in studies performed in several members of a Swiss family with hereditary acatalasia.
An assay dependent on the inordinate sensitivity of acatalasic erythrocytes to H202 demonstrated that ascorbic acid, hydroquinone, and aged primaquine generated H202 in vitro. Fresh primaquine and acetylphenylhydrazine did not.
Despite in vitro sensitivity to H202, the survival in vivo of Cr51-labeled acatalasic erythrocytes was not apparently curtailed either before or during, the ingestion of large quantities of primaquine or ascorbic acid.
Acatalasic erythrocytes metabolized glucose through the hexosemonophosphate (HMP) shunt at three times the normal rate and increased this rate many times when exposed to levels of peroxide-generating drugs that had negligible effect on normal erythrocytes. Excessive shunt activity resulted from the peroxidation of glutathione, blockade of which by N-ethylmaleimide produced striking oxidative injury to acatalasic but not to normal erythrocytes. When erythrocytes lacked both their HMP shunt and catalase, oxidative damage by H202 was greater than with either deficiency alone.
These findings indicate that H202 is not involved in oxidative hemolysis induced by acetylphenylhydrazine and its congeners, although it is generated on standing by primaquine. In acatalasia, the oxidative challenge of H202 whether spontaneously generated or drug-induced, is dissipated by glutathione peroxidation. Therefore, H202 both stimulates and is offset by hexosemonophosphate shunt activation. In the normal erythrocyte, this mechanism and catalasic decomposition combine to prevent oxidative injury; when both mechanisms are overcome, H202 induces irreversible oxidative damage.
